| INR n = 57 | IR n = 56 | NC n = 22 |
---|---|---|---|
Gender | Â | Â | Â |
 Male | 78.9% (45) | 55.4% (31) | 45.5% (10) |
 Female | 21.1% (12) | 44.6% (25) | 54.5% (12) |
Age (years) | Â | Â | Â |
 21–40 | 12.3% (7) | 23.2% (13) | 18.2% (4) |
 41–60 | 52.6% (30) | 66.1% (37) | 54.5% (12) |
 61–80 | 35.1% (20) | 10.7% (6) | 27.3% (6) |
BMI | 19.39 ± 4.45 | 20.54 ± 2.26 | 20.06 ± 6.24 |
HIV transmission category | Â | Â | Â |
 Heterosexual | 96.5% (55) | 98.2% (55) | 100% (22) |
 Homosexual | 3.5% (2) | 0.0% | 0.0% |
 Injection drug user | 0.0% | 1.8% (1) | 0.0% |
Regimen | Â | Â | Â |
 TDF + 3TC + EFV | 61.4% (35) | 44.6% (25) | 68.2% (15) |
 AZT/3TC + EFV | 19.3% (11) | 23.2% (13) | 18.2% (4) |
 Other | 19.3% (11) | 32.2% (18) | 10.7% (3) |
Baseline CD4+ T Counts (cells/μL) | 92.91 ± 94.53 | 115.22 ± 79.29 | 561 ± 199.91 |
Baseline CD8+ T Counts (cells/μL) | 785.41 ± 462.31 | 728.01 ± 437.47 | 1165.41 ± 488.1 |
Baseline CD4/CD8 ratio | 0.13 ± 0.15 | 0.18 ± 0.15 | 0.53 ± 0.18 |
Baseline WBC (× 109 / L) | 5.04 ± 1.61 | 5.03 ± 1.86 | 7.65 ± 3.62 |
Last CD4+ T Counts (cells/μL) | 145.11 ± 36.43 | 404.64 ± 122.41 | 727.91 ± 188.07 |